Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine

2012 ◽  
Vol 13 (9) ◽  
pp. 1023-1035 ◽  
Author(s):  
Hye In Woo ◽  
Ka-Kyung Kim ◽  
Hangseok Choi ◽  
Seonwoo Kim ◽  
Kee-Taek Jang ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Clinical Outcomes ◽  
Genetic Polymorphisms ◽  
Therapeutic Response

scholarly journals P31-7 Clinical outcomes of cerebral infarction associated with Trousseau’s syndrome in advanced pancreatic cancer patients

2021 ◽  
Vol 32 ◽  
pp. S350
Author(s):  
Tomoyo Oguri ◽  
Hiroyuki Takeda ◽  
Kumiko Umemoto ◽  
Ayako Doi ◽  
Hiroyuki Arai ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cerebral Infarction ◽  
Cancer Patients ◽  
Clinical Outcomes ◽  
Advanced Pancreatic Cancer ◽  
Trousseau’S Syndrome

scholarly journals Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy

2011 ◽  
Vol 10 (10) ◽  
pp. 1993-1999 ◽  
Author(s):  
Seung Tae Kim ◽  
Do Hyoung Lim ◽  
Kee-Taek Jang ◽  
Taekyu Lim ◽  
Jeeyun Lee ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Clinical Outcomes ◽  
First Line ◽  
Kras Mutations

scholarly journals Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus

2021 ◽  
Author(s):  
A. Carrato ◽  
L. Cerezo ◽  
J. Feliu ◽  
T. Macarulla ◽  
E. Martín-Pérez ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Clinical Outcomes ◽  
Health Care Professionals ◽  
Unmet Need ◽  
Screening Tools ◽  
Therapeutic Management ◽  
Care Process ◽  
Nutritional Screening

Abstract Purpose Malnutrition is a common problem among pancreatic cancer (PC) patients that negatively impacts on their quality of life (QoL) and clinical outcomes. The main objective of this consensus is to address the role of Medical Nutrition Therapy (MNT) into the comprehensive therapeutic management of PC patients. Methods A Spanish multidisciplinary group of specialists from the areas of Medical Oncology; Radiation Oncology; Endocrinology and Nutrition; and General Surgery agreed to assess the role of MNT as part of the best therapeutic management of PC patients. Results The panel established different recommendations focused on nutritional screening and nutritional screening tools, MNT strategies according to PC status, and MNT in palliative treatment. Conclusions There is an unmet need to integrate nutritional therapy as a crucial part of the multimodal care process in PC patients. Health authorities, health care professionals, cancer patients, and their families should be aware of the relevance of nutritional status and MNT on clinical outcomes and QoL of PC patients.

scholarly journals Genetic Polymorphisms of Matrix Metalloproteinases and Clinical Outcomes in Colorectal Cancer Patients

2013 ◽  
Vol 10 (8) ◽  
pp. 1022-1027 ◽  
Author(s):  
Wen-Chien Ting ◽  
Lu-Min Chen ◽  
Jiunn-Bey Pao ◽  
Ying-Pi Yang ◽  
Bang-Jau You ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Matrix Metalloproteinases ◽  
Cancer Patients ◽  
Clinical Outcomes ◽  
Genetic Polymorphisms ◽  
Colorectal Cancer Patients

scholarly journals Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients

2019 ◽  
Vol 40 (4) ◽  
pp. 544-550 ◽  
Author(s):  
Manuel Gentiluomo ◽  
Paula Puchalt García ◽  
Alice Alessandra Galeotti ◽  
Renata Talar-Wojnarowska ◽  
Christine Tjaden ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Genetic Variability ◽  
Cancer Patients ◽  
Clinical Outcomes

Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients

2020 ◽  
Vol 20 (5) ◽  
pp. 647-654
Author(s):  
Stéphanie Bonnet ◽  
Sabrina Falkowski ◽  
Marine Deppenweiler ◽  
Caroline Monchaud ◽  
Hélène Arnion ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Clinical Outcomes ◽  
Genetic Polymorphisms
Sign in / Sign up

Export Citation Format

Share Document